[1]
S. Yıldırım, “Impact of Blood Type on Treatment Response and Survival in HER2-Negative Metastatic Gastric Cancer”, Cerrahpaşa Medical Journal, vol. 49, no. 1, pp. 1–6, Oct. 2025.